J. Baird

发表

A Novel Agonist of the TRIF Pathway Induces a Cellular State Refractory to Replication of Zika, Chikungunya, and Dengue Viruses

E. Haddad, Jessica L Smith, Shelly A Bambina, 2017, mBio.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Manish R. Patel, Charles J. Vaske, Joe Y. Chang, 2016, Journal for Immunotherapy of Cancer.

Optimizing Timing of Immunotherapy Improves Control of Tumors by Hypofractionated Radiation Therapy

B. Fox, P. Newell, Shelly A Bambina, 2016, PloS one.

Evaluation of Explant Responses to STING Ligands: Personalized Immunosurgical Therapy for Head and Neck Squamous Cell Carcinoma.

R. Bell, T. D. de Gruijl, Shelly A Bambina, 2018, Cancer research.

Programmed cell death‐1 blockade enhances response to stereotactic radiation in an orthotopic murine model of hepatocellular carcinoma

S. Friedman, P. Newell, M. Crittenden, 2017, Hepatology research : the official journal of the Japan Society of Hepatology.

Tumor cure by radiation therapy and checkpoint inhibitors depends on pre-existing immunity

A. Alice, Shelly A Bambina, M. Crittenden, 2018, Scientific Reports.

STING expression and response to treatment with STING ligands in premalignant and malignant disease

B. Fox, R. Bell, Zipei Feng, 2017, PloS one.

Radiotherapy Combined with Novel STING-Targeting Oligonucleotides Results in Regression of Established Tumors.

Shelly A Bambina, D. Kanne, M. Crittenden, 2016, Cancer research.

Stimulating Innate Immunity to Enhance Radiation Therapy-Induced Tumor Control.

W. Murphy, A. Monjazeb, M. Crittenden, 2017, International journal of radiation oncology, biology, physics.

Dendritic Cell Maturation Defines Immunological Responsiveness of Tumors to Radiation Therapy

A. Alice, Shelly A Bambina, M. Broz, 2020, The Journal of Immunology.

Amplifying IFN-γ Signaling in Dendritic Cells by CD11c-Specific Loss of SOCS1 Increases Innate Immunity to Infection while Decreasing Adaptive Immunity

A. Alice, Shelly A Bambina, M. Crittenden, 2018, The Journal of Immunology.

A platform for locoregional T-cell immunotherapy to control HNSCC recurrence following tumor resection

R. Bell, Shelly A Bambina, S. Jensen, 2021, Oncotarget.

Immune-Mediated Regression of Established B16F10 Melanoma by Intratumoral Injection of Attenuated Toxoplasma gondii Protects against Rechallenge

P. Lizotte, S. Fiering, M. Bosenberg, 2013, The Journal of Immunology.

This information is current as against Rechallenge Protects Toxoplasma gondii of Attenuated InjectionB 16 F 10 Melanoma by Intratumoral Immune-Mediated Regression of Established

P. Lizotte, S. Fiering, M. Bosenberg, 2012 .

Expression of Arginase I in Myeloid Cells Limits Control of Residual Disease after Radiation Therapy of Tumors in Mice

P. Newell, A. Jackson, M. Crittenden, 2014, Radiation research.

Attenuated Listeria monocytogenes reprograms M2-polarized tumor-associated macrophages in ovarian cancer leading to iNOS-mediated tumor cell lysis

P. Lizotte, S. Fiering, P. Lauer, 2014, Oncoimmunology.

ICOS is upregulated on T cells following radiation and agonism combined with radiation results in enhanced tumor control

M. Gostissa, Shelly A Bambina, M. Crittenden, 2022, Scientific Reports.

Fluorescent tracking identifies key migratory dendritic cells in the lymph node after radiotherapy

B. Piening, A. Alice, Shelly A Bambina, 2022, Life Science Alliance.

Crittenden, Marka R. and Baird, Jason and Malecka, Anna and Jackson, Andrew M. and Gough, Michael J. (2016) Mertk on tumor macrophages is a therapeutic target to prevent tumor recurrence following radiation

Lauren, P. Newell, E. Akporiaye, 2017 .

Ideal Timing of Immunotherapy With Radiation in Murine Tumor Models

M. Crittenden, M. Gough, J. Baird, 2014 .

Targeting MerTK enhances adaptive immune responses following radiotherapy.

O. McCarty, M. Baine, Shelly A Bambina, 2020, International journal of radiation oncology, biology, physics.

Mertk on tumor macrophages is a therapeutic target to prevent tumor recurrence following radiation therapy

P. Newell, E. Akporiaye, A. Alice, 2016, Oncotarget.

Optimal Targeting of HER 2 – PI 3 K Signaling in Breast Cancer : Mechanistic Insights and Clinical Implications

A. Schetter, S. Groshen, E. Bowman, 2013 .

Explant Modeling of the Immune Environment of Head and Neck Cancer

Shelly A Bambina, N. Casap, R. Leidner, 2021, Frontiers in Oncology.

Activating the Nucleic Acid-Sensing Machinery for Anticancer Immunity.

A. Alice, M. Gough, Alejandro F. Alice, 2019, International review of cell and molecular biology.

Phagocytes mediate targeting of iron oxide nanoparticles to tumors for cancer therapy.

S. Barry, S. Fiering, E. Demidenko, 2013, Integrative biology : quantitative biosciences from nano to macro.

Ovarian cancer progression is controlled by phenotypic changes in dendritic cells

A. M. Rauwerdink, S. Fiering, J. Cubillos-Ruiz, 2012, The Journal of experimental medicine.

TGFβ Inhibition Prior to Hypofractionated Radiation Enhances Efficacy in Preclinical Models

P. Newell, E. Akporiaye, M. Crittenden, 2014, Cancer Immunology Research.

Dual Positive and Negative Regulation of Wingless Signaling by Adenomatous Polyposis Coli

H. Benchabane, J. Baird, S. Kent, 2008, Science.

SARS-CoV-2 Antibodies Detected in Mother’s Milk Post-Vaccination

B. Fox, W. Urba, S. Jensen, 2021, Journal of human lactation : official journal of International Lactation Consultant Association.

Adenomatous polyposis coli is present near the minimal level required for accurate graded responses to the Wingless morphogen

H. Benchabane, J. Baird, Carter M. Takacs, 2008, Development.

Local hyperthermia treatment of tumors induces CD8(+) T cell-mediated resistance against distal and secondary tumors.

P Jack Hoopes, S. Fiering, Peisheng Zhang, 2014, Nanomedicine : nanotechnology, biology, and medicine.

TGF b Inhibition Prior to Hypofractionated Radiation Enhances Ef fi cacy in Preclinical Models

P. Newell, E. Akporiaye, M. Crittenden, 2014 .

efficacy in preclinical models inhibition prior to hypofractionated radiation enhances β TGF

P. Newell, E. Akporiaye, M. Crittenden, 2014 .

Reprogramming tumor-associated dendritic cells in vivo using miRNA mimetics triggers protective immunity against ovarian cancer.

M. Korc, S. Fiering, L. Sempere, 2012, Cancer research.

Characterization of a Novel Compound That Stimulates STING-Mediated Innate Immune Activity in an Allele-Specific Manner

L. Trautmann, E. Haddad, Jinu Abraham, 2020, Frontiers in Immunology.

MV-626, a potent and selective inhibitor of ENPP1 enhances STING activation and augments T-cell mediated anti-tumor activity in vivo

M. Gallatin, M. Crittenden, M. Gough, 2018 .

Avirulent Toxoplasma gondii generates therapeutic antitumor immunity by reversing immunosuppression in the ovarian cancer microenvironment.

P. Lizotte, S. Fiering, J. Cubillos-Ruiz, 2013, Cancer research.

Microenvironment and Immunology Reprogramming Tumor-Associated Dendritic Cells In Vivo UsingmiRNAMimetics Triggers Protective Immunity against Ovarian Cancer

M. Korc, S. Fiering, L. Sempere, 2012 .

Radiotherapy Combined with Novel STING-Targeting Oligonucleotides Results in Regression of Established Tumors.

Shelly A Bambina, D. Kanne, M. Crittenden, 2016, Cancer research.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Charles J. Vaske, Joe Y. Chang, Scott R. Presnell, 2016, Journal for ImmunoTherapy of Cancer.

Evaluation of Explant Responses to STING Ligands: Personalized Immunosurgical Therapy for Head and Neck Squamous Cell Carcinoma.

T. D. de Gruijl, R. Leidner, M. Crittenden, 2018, Cancer research.